News
Zydus' Novel Orally Administered GLP-1 Agonist - 'ZYOG1' to treat Diabetes and Obesity Enters Phase I Clinical Trial
June 20, 2010 10:34 pm | by Bio-Medicine.Org | CommentsAHMEDABAD, India , June 21, 2010 /- Zydus Cadila, a global healthcare provider and one of India's leading healthcare companies has received Phase I clinical trial permission from the DCGI for ZYOG1 - a novel GLP-1 agonist. Designed and developed at the Zydus Research Centre using a unique...
Compost filter socks improve runoff from croplands
June 20, 2010 8:38 pm | by EurekAlert | Comments(American Society of Agronomy) Study finds that compost filters socks can reduce soil erosion from croplands and reduce the amount of herbicide in runoff.
Flame retardant linked to altered thyroid hormone levels during pregnancy
June 20, 2010 8:38 pm | by EurekAlert | Comments(University of California - Berkeley) A new UC Berkeley-led study of pregnant women links higher blood levels of PBDEs, a common type of flame retardant, with altered thyroid hormone levels. Normal maternal thyroid levels are important for healthy fetal neurodevelopment.
Drug Targets Lupus by Tricking Immune System
June 20, 2010 8:35 pm | by Massachusetts Institute of Technology | CommentsA new approach shows early promise in fighting the devastating disease.
Targeting disease remission has socio-economic benefits over low disease activity
June 19, 2010 2:37 am | by EurekAlert | Comments(European League Against Rheumatism) Achieving disease remission in patients with rheumatoid arthritis (RA) provides superior outcomes across measures of socio-economic importance including work productivity and quality of life according to results presented today at EULAR 2010,...
Blood deficiencies are strong predictors of poor outcome
June 19, 2010 2:33 am | by EurekAlert | Comments(European League Against Rheumatism) For health care professionals diagnosing primary Sjogren's Syndrome (pSS, an autoimmune disorder in which immune cells attack and destroy moisture-producing glands), the incidence of blood based deficiencies is the strongest predictor of a poor...
Sex lives of patients are negatively affected by rheumatoid arthritis and SLE
June 18, 2010 4:37 pm | by EurekAlert | Comments(European League Against Rheumatism) Systemic Lupus Erythematosus patients from Brazil and Rheumatoid Arthritis patients from France report that their rheumatic conditions negatively affect their emotional relationships and sex lives, according to research presented today at EULAR...
UPDATE: Congress set to restore Medicare reimbursement next week
June 18, 2010 4:36 pm | by Mass Device | CommentsCongress is set to restore Medicare reimbursement for physicians next week, after a 21 percent cut went into effect June 18. Congress is set to restore Medicare reimbursement rates for physicians next week, meaning a de facto 2.2 percent pay raise, after a 21 percent cut went...
Delcath CEO Hobbs takes top spot on Capella's board
June 18, 2010 4:36 pm | by Mass Device | CommentsEamonn Hobbs, CEO of Delcath Systems, is tapped to be Irish stent maker Capella Inc.'s chairman of the board. Eamonn Hobbs took over as board chairman for Irish stent-maker Capella Inc. Hobbs is CEO of Delcath Systems Inc. (NSDQ:DCTH), a New York-based manufacturer of...
CytoPherx drums up $11.7 million for dialysis development
June 18, 2010 4:35 pm | by Mass Device | CommentsCytoPherx Inc. raises $11.7 million in equity, debt and options to develop a device that filters the blood of kidney-disease patients. By Brandon Glenn CytoPherx Inc. raised $11.7 million for the development of a device that filters the blood of kidney-disease patients. The Ann...
Coffee May Protect Against Head and Neck Cancers
June 18, 2010 4:34 pm | by AACR | CommentsThe embargo has been lifted on the AACR press release: “Coffee May Protect Against Head and Neck Cancers,†due to a violation by Drug Discovery and Development and the Sci-Tech Heretic blog. Reporters may post their stories effective immediately. • Caffeinated coffee protected against...
Leaking Packaging, GMP Issues Result in Artegraft Warning
June 18, 2010 4:31 pm | by U.S. Food & Drug Administration | CommentsRecurring complaints of leaking packages of natural collagen vascular grafts have resulted in a warning letter to Artegraft that cites a number of good manufacturing (GMP) problems related to the leaks.
FDA Acknowledges Corrections, Sends Optovue Warning Letter
June 18, 2010 4:31 pm | by U.S. Food & Drug Administration | CommentsAlthough Optovue is taking corrective action to bring a normative database used with its RTVue optical coherence tomography into compliance, it received a warning letter that notes the effectiveness of the corrections can’t be fully reviewed and evaluated because they are ongoing.
Boston Scientific: Heart device helps women more
June 18, 2010 10:45 am | by The Associated Press | CommentsMedical device maker Boston Scientific Corp. said Friday women received a greater benefit than men from its cardiac resynchronization therapy defibrillators, according to an analysis of clinical trial data.Cardiac resynchronization therapy defibrillators shock the heart to correct irregular...
Medtronic says study shows faster catheter work
June 18, 2010 8:45 am | by The Associated Press | CommentsMedical device maker Medtronic Inc. said Friday late-stage study data shows two catheters it is seeking approval for in the United States work faster than a traditional approach in helping doctors treat forms of atrial fibrillation, a condition that could trigger a stroke.The Minneapolis...
